PRESS RELEASE published on 04/16/2024 at 07:45, 1 year 9 months ago Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets Marinomed Biotech AG announces 2023 financial year results, highlighting progress with Marinosolv and Carragelose assets. Focus on achieving operating profitability and commercialization 2023 Financial Year Operating Profitability Marinomed Biotech AG Marinosolv Carragelose Assets
BRIEF published on 04/11/2024 at 07:50, 1 year 10 months ago Marinomed Biotech AG Announces Dual Market Expansion for Carragelose Products Carragelose Market Expansion Marinomed Biotech Nasal Spray Allergen-blocking
BRIEF published on 04/11/2024 at 07:50, 1 year 10 months ago Marinomed Biotech AG annonce une double expansion du marché pour les produits à base de carragelose Marinomed Biotech L'expansion Du Marché Carrragélose Spray Nasal Blocage Des Allergènes
PRESS RELEASE published on 04/11/2024 at 07:45, 1 year 10 months ago Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico Marinomed Biotech AG expands Carragelose product portfolio with new launches in Austria and Mexico, targeting new indications and key markets Mexico Marinomed Biotech AG Carragelose Allergen-blocking Austria
BRIEF published on 03/28/2024 at 07:50, 1 year 10 months ago Marinomed Biotech AG Secures Loan Repayment Deferral with European Investment Bank Marinomed Biotech AG European Investment Bank Loan Repayment Deferral Marinosolv Platform Carragelose Business Expansion
BRIEF published on 03/28/2024 at 07:50, 1 year 10 months ago Marinomed Biotech AG obtient un report de remboursement de son prêt auprès de la Banque européenne d'investissement Marinomed Biotech AG Banque Européenne D'investissement Report De Remboursement Du Prêt Plateforme Marinosolv Expansion Des Activités De Carragelose
PRESS RELEASE published on 03/28/2024 at 07:45, 1 year 10 months ago Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months Marinomed Biotech AG European Investment Bank Deferral Agreement Marinosolv Platform Venture Loan
BRIEF published on 03/26/2024 at 07:50, 1 year 10 months ago Marinomed Biotech AG Expands Carragelose Distribution in Gulf Region and Eastern Europe Carragelose Marinomed GAIA Healthcare VitaPlus Kft Pharmaceutical Distribution
BRIEF published on 03/26/2024 at 07:50, 1 year 10 months ago Marinomed Biotech AG étend la distribution de carragelose dans la région du Golfe et en Europe de l'Est VitaPlus Kft Marinomé Carrragélose GAIA Santé Distribution Pharmaceutique
PRESS RELEASE published on 03/26/2024 at 07:45, 1 year 10 months ago Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe Marinomed Biotech AG partners with GAIA Healthcare FZ LLC and VitaPlus Kft. to distribute Carragelose nasal sprays in Gulf region and Eastern Europe, expanding market reach Marinomed Biotech AG Carragelose Distribution Partnerships GAIA Healthcare FZ LLC VitaPlus Kft.
Published on 02/11/2026 at 14:35, 6 hours 5 minutes ago Worksport Delivers Breakout Q4: Revenue Up 65% YoY, Gross Profit Up 380%
Published on 02/11/2026 at 14:30, 6 hours 10 minutes ago Sekur Private Data CEO Updates on Growth, Market Expansion, Corporate Developments and New Product Launch
Published on 02/11/2026 at 14:00, 6 hours 40 minutes ago Organto Foods Inc. Expands Scalable and Flexible Logistics Platform to Support 2026 Growth
Published on 02/11/2026 at 14:00, 6 hours 40 minutes ago PPX Mining Provides Operational and Corporate Update
Published on 02/11/2026 at 14:00, 6 hours 40 minutes ago Meta Critical Minerals Engages Quad Consulting Group to Advance Table Mountain Silica Project Development Strategy
Published on 02/11/2026 at 19:52, 48 minutes ago LR Health & Beauty SE lays foundation for positive future business performance with new financing structure
Published on 02/11/2026 at 19:50, 49 minutes ago EQS-Adhoc: LR HEALTH & BEAUTY SE REACHES AN AGREEMENT WITH BONDHOLDERS AND SHAREHOLDER REGARDING A COMPREHENSIVE RESTRUCTURING OF THE 2024/2028 BOND – EUR 20 MILLION IN NEW CAPITAL AND ...
Published on 02/11/2026 at 18:31, 2 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/11/2026 at 18:00, 2 hours 40 minutes ago Private Equity Holding AG: Net Asset Value as of January 31, 2026
Published on 02/11/2026 at 17:45, 2 hours 55 minutes ago Infotel : Stake held in AeroEx. A publisher of digital compliance and safety solutions for the aerospace industry.
Published on 02/11/2026 at 17:45, 2 hours 55 minutes ago Infotel : Prise de participation dans AeroEx éditeur de solutions digitales de conformité et de sécurité pour l’industrie aéronautique.
Published on 02/11/2026 at 11:25, 9 hours 14 minutes ago Innelec : Mise à disposition du rapport financier semestriel 2025-26
Published on 02/11/2026 at 08:00, 12 hours 40 minutes ago Imerys-press-release French State acquisition stake Emili Lithium
Published on 02/11/2026 at 08:00, 12 hours 40 minutes ago Imerys-communique-de-presse prise participation Etat Français Projet lithium Emili
